1. Infinity Pharmaceuticals, Inc. (20 from 108 patents)

2. Millennium Pharmaceuticals Limited (11 from 850 patents)

3. Sanofi-a Ventis Deutschland Gmbh (2 from 1,827 patents)

4. Infinity Discovery, Inc. (2 from 12 patents)

5. Proscript, Inc. (2 from 4 patents)

6. Other (1 from 832,680 patents)

7. National Institutes of Health, a Component of the US Dept. of Health & Human Services (1 from 3,435 patents)

8. Aventis Pharma Deutschland, Gmbh (1 from 330 patents)

9. Leukosite, Inc. (1 from 5 patents)

10. Elicio Therapeutics, Inc. (1 from 4 patents)

11. Millennium Pharmacueticals, Inc. (1 from 2 patents)

1. 12138301 - Compounds including a mutant KRAS sequence and a lipid and uses thereof

2. 9248124 - Use of inhibitors of IκB kinase for the treatment of cancer

3. 9108989 - Inhibitors of fatty acid amide hydrolase

4. 8703755 - Analogs of benzoquinone-containing ansamycins and methods of use thereof

5. 8629125 - Inhibitors of fatty acid amide hydrolase

6. 8378099 - Boronic ester and acid compounds, synthesis and uses

7. 8349814 - Inhibitors of fatty acid amide hydrolase

8. 8329675 - Inhibitors of fatty acid amide hydrolase

9. 8252779 - Analogs of benzoquinone-containing ansamycins and methods of use thereof

10. 8236956 - Cyclopamine analogues and methods of use thereof

11. 8003634 - Analogs of benzoquinone-containing ansamycins and methods of use thereof

12. 8003791 - Boronic ester and acid compounds, synthesis and uses

13. 7947663 - Inhibitors of fatty acid amide hydrolase

14. 7875628 - Cyclopamine analogues and methods of use thereof

15. 7833997 - Analogs of benzoquinone-containing ansamycins and methods of use thereof